Page last updated: 2024-10-25

6-hydroxychlorzoxazone and Fatty Liver

6-hydroxychlorzoxazone has been researched along with Fatty Liver in 2 studies

6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL) have a different prognosis and should be dealt with differently."1.34Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. ( Chtioui, H; Dufour, JF; Ledermann, M; Semela, D; Zimmermann, A, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prompila, N1
Wittayalertpanya, S1
Komolmit, P1
Chtioui, H1
Semela, D1
Ledermann, M1
Zimmermann, A1
Dufour, JF1

Other Studies

2 other studies available for 6-hydroxychlorzoxazone and Fatty Liver

ArticleYear
Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:5

    Topics: Adult; Case-Control Studies; Chlorzoxazone; Chromatography, High Pressure Liquid; Cytochrome P-450 C

2008
Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:6

    Topics: Adult; Biopsy; Biotransformation; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diagnosis, Differential; F

2007